The FDA issued draft guidance on oncology clinical trials, taking the first steps toward formalizing a position that it's ...
In August, the FDA also approved updated mRNA COVID-19 vaccines, which also have a "monovalent (single) component" ...
These extra doses will bring more highly specialised work making these novel molecules to contract manufacturing ...
The U.S. Food and Drug Administration (FDA) on Thursday approved Pfizer and Moderna's updated COVID-19 vaccines amid a summer wave of "very high" coronavirus levels in wastewater, according to the ...
On August 22, Moderna announced that FDA approved its supplemental Biologics License Application ... we saw more than 600,000 hospitalizations due to COVID in the U.S.” On the same day, Pfizer and ...
The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...
KP.2-adapted COVID-19 vaccine received FDA approval. Manufacturing Optimization Program aims to deliver $1.5b in savings by ...
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced its Phase 2 study ... iv Despite its severity, there are no FDA-approved treatments for cachexia. iii About Ponsegromab ...
Pfizer's recent financial performance shows 14% YoY operational growth excluding COVID sales. Check out more on PFE stock ...
Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback